Bronchiectasis is a vast problem. We’ve made it our problem.

Bronchiectasis is an underdiagnosed chronic lung disease characterized by recurrent cough, excessive sputum production, and frequent pulmonary exacerbations. Diagnoses of bacterial infections lead to rapid decline in quality of life, hospitalizations, and increased mortality. There currently are no FDA-approved treatments specifically indicated for these patients. The heterogeneity of this patient population requires a careful, patient-centric approach to each target subpopulation